Sep 15, 2021 / 08:30PM GMT
Operator
Good afternoon and welcome to Moderna's COVID-19 vaccine update. (Operator Instructions) Please be advised that this call is being recorded.
At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.
Lavina Talukdar - Moderna, Inc. - Senior VP & Head of IR
Thank you, operator, and hello, everyone, and thank you for joining us on today's call to discuss new data points, including clinical data and analysis from our 1-year follow-up of our Phase III COVE study. You can access the press release issued this afternoon as well as the slides that we will be reviewing by going to the Investors section of our website.
On today's call are Stephane Bancel, our Chief Executive Officer; Stephen Hoge, our President; Paul Burton, our Chief Medical Officer; and Jacqueline Miller, Senior Vice President, Therapeutic Head of Infectious Diseases at Moderna.
Before we begin, please note that this conference call will include forward-looking statements made pursuant to the safe harbor
Moderna Inc COVID-19 Vaccine Update Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot